Despite conventional wisdom that the 23andMe business breakthrough is the direct-to-consumer model, it’s also the consolidation of genetic testing, diagnosis and drug development that has the potential to change the industry.
The question is not whether you should do it, but how to do it successfully
Get the most out of
Register for free and enjoy unlimited access to: